About: Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article by Benjamin A. Lipsky et al published 6 June 2007 in Journal of Antimicrobial Chemotherapy

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2007 (uk) im Juni 2007 veröffentlichter wissenschaftlicher Artikel (de) article by Benjamin A. Lipsky et al published 6 June 2007 in Journal of Antimicrobial Chemotherapy (en)
publication date	wds:Q57543731-1706D6D1-18C8-429F-9B5F-C2C7589BDDCA
publication date	2007-06-06 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57543731-6F735519-AFA9-42AB-88B7-E33E2BA70CF8
language of work or name	English
cites work	wds:Q57543731-186D124F-5C99-4341-9DAB-5438D93D8646 wds:Q57543731-1C14C52F-2866-43AD-B84E-55802046F9FD wds:Q57543731-4AA5CFCF-ADED-4F69-BFFD-7CF9EFB690D6 wds:Q57543731-55D2100C-9D84-4524-8750-6CFC32DDD2CF wds:Q57543731-5731D83E-9F53-463B-AF78-56D5B4B4F583 wds:Q57543731-60FDF4A2-7CBF-4301-9D81-C0F85CFB226D wds:Q57543731-6461FA1E-61B8-4A5B-BFAE-F1DE29B5FAFD wds:Q57543731-701BB8F5-9C93-45EF-B2DF-2D951EBB889E wds:Q57543731-72263815-4407-404B-9D8B-302785AE1204 wds:Q57543731-73B73A9F-0C5A-4D2D-BE0B-EDE2F0A9EB12 wds:Q57543731-8D04455C-66A3-488E-90BC-1E66A9763AC3 wds:Q57543731-8DA810C3-C593-45CA-B983-5066CE16DDFE wds:Q57543731-9915D8CE-022B-4B85-9118-901DAC9123ED wds:Q57543731-A707A3EA-0DB9-47F9-BC35-2AB58911E1A2 wds:Q57543731-B335D2BF-DEE2-46BA-B3F6-DE33FD27CEBC wds:Q57543731-B6DD3586-65F3-4233-880A-EACD3CDBBEC8 wds:Q57543731-B9262FE4-9221-4755-AE07-986D8C96B30E wds:Q57543731-C02FD9A1-0E7D-40EE-9893-7AF85706DBA9 wds:Q57543731-CCBD2D9D-57AA-449F-AA65-33CC9322B992 wds:Q57543731-D225DD5C-0BA1-4959-80C2-33363D77A612 wds:Q57543731-E82F60F3-E6BF-453E-9DE7-FCB42545A95D wds:Q57543731-F7138F4F-596F-49B0-B0D9-87F3CB3D6909 wds:Q57543731-F933D88B-1832-412F-8C13-8C2198AA56FB
cites work	Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. A summary of guidelines for managing the diabetic foot Diagnosis and treatment of diabetic foot infections Once-daily, high-dose levofloxacin versus ticarcillin-clavulanate alone or followed by amoxicillin-clavulanate for complicated skin and skin-structure infections: a randomized, open-label trial Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection In vitro activity of moxifloxacin, a new 8-methoxyquinolone, against gram-positive bacteria. A practical guide to the treatment of complicated skin and soft tissue infections Moxifloxacin: a review of its use in the management of bacterial infections Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients Advances in the treatment of diabetic foot infections Penetration of Moxifloxacin into Healthy and Inflamed Subcutaneous Adipose Tissues in Humans The use of fluoroquinolones in the treatment of skin infections Newer treatment options for skin and soft tissue infections Empirical therapy for diabetic foot infections: are there clinical clues to guide antibiotic selection? Risk Factors for Foot Infections in Individuals With Diabetes In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections Clinafloxacin versus piperacillin/tazobactam in the treatment of severe skin and soft-tissue infections in adults at a Veterans Affairs medical center Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections A report from the international consensus on diagnosing and treating the infected diabetic foot Evidence-based antibiotic therapy of diabetic foot infections
author name string	wds:Q57543731-0CC39DEF-A42B-435C-94FF-60261D2200B5 wds:Q57543731-2FB7D61E-9CA5-4F9D-8AC8-F6D64562D043 wds:Q57543731-5D38299C-0658-442A-A9EE-15D6C87AF5F8
author name string	James Song Shurjeel Choudhri Philip Giordano
rdfs:label	Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate (en) Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate (nl)
skos:prefLabel	Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate (en) Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate (nl)
name	Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate (en) Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate (nl)
author	wds:Q57543731-59F5ACF3-2536-4550-9B6B-3C5961049729
author	Benjamin A. Lipsky
title	wds:Q57543731-FBD2EC02-4C20-4B95-8BEB-98BB6E919A1E
title	Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin–tazobactam/amoxicillin–clavulanate (en)
page(s)	wds:Q57543731-F5903ECB-ED80-467C-9647-BCFA618AC0F4
page(s)	370-376
instance of	wds:Q57543731-BCC90BD1-57D3-491D-9450-94CD5A85F4E7
instance of	scholarly article
main subject	wds:Q57543731-0B4474F4-2FBA-44ED-AC0B-CEB5CE1B6B4D
main subject	moxifloxacin
PubMed ID	wds:Q57543731-B9769F0F-C2C4-438D-8BA8-49D11687AAC7
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17553812
PubMed ID	17553812
published in	wds:Q57543731-219C02D3-163E-48BA-99C6-6D04A42605BE
published in	Journal of Antimicrobial Chemotherapy
issue	wds:Q57543731-55B45DDC-1FB9-4AC0-81C2-747EE2049E94
volume	wds:Q57543731-A363EC15-C6F8-4F09-B60E-EB2AE9FE0403
issue	2
volume	60
DOI	wds:Q57543731-5F04143D-A07C-45CC-A112-522F5174DD23
DOI	http://dx.doi.org/10.1093/JAC/DKM130
DOI	10.1093/JAC/DKM130
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57543731
is cites work of	10 years' experience with the pneumococcal quinolone moxifloxacin The evaluation and treatment of complicated skin and skin structure infections Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream Sequential intravenous/oral moxifloxacin monotherapy for complicated skin and skin structure infections: a meta-analysis of randomised controlled trials Current medical management of diabetic foot infections Outcomes in controlled and comparative studies on non-healing wounds: recommendations to improve the quality of evidence in wound management A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study The treatment of diabetic foot infections: focus on ertapenem Efficacy and safety of sequential intravenous/oral moxifloxacin vs intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software